Prostate Cancer: To Screen or Not to Screen?

Alex Shteynshlyuger, Gerald L. Andriole

Research output: Contribution to journalReview article

13 Scopus citations

Abstract

The debate about the usefulness of population-based prostate cancer screening has been ongoing for decades. The most current evidence shows limited benefit of population screening, and significant psychological, physical and financial costs. Efforts to improve screening with better markers and more selective treatment may make population-based screening more effective.

Original languageEnglish
Pages (from-to)1-9
Number of pages9
JournalUrologic Clinics of North America
Volume37
Issue number1
DOIs
StatePublished - Feb 1 2010

Keywords

  • ERSPC trial
  • PLCO trial
  • Prostate cancer
  • Prostate-specific antigen
  • Screening

Fingerprint Dive into the research topics of 'Prostate Cancer: To Screen or Not to Screen?'. Together they form a unique fingerprint.

  • Cite this